Bernstein kept Sell on Givaudan stock at CHF 2,886.00

Published on 10/12/2026 at 10:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bernstein kept Sell at CHF 2,886 on October 8, 2026. Givaudan stock was EUR 3,692.50 on October 12, 2026 after H1 sales of CHF 3.8 billion.

Key points in brief

Bernstein maintained a Sell rating on Givaudan with a CHF 2,886.00 price target on October 8, 2026.
Barclays had upgraded Givaudan to Overweight and raised its target to CHF 3,850.00 on October 5, 2026.
First-half 2026 sales reached CHF 3.8 billion, up 3.6 percent like-for-like.
Givaudan stock was at EUR 3,692.50 at Lang & Schwarz on October 12, 2026.

A high-contrast black and white documentary photograph of an aroma evaluation session. A row of tasters sit along a long table, each holding white scent strips to their noses. Rows of small unlabelled vials are arranged before them. Harsh directional flas — Givaudan CH0010645932 Schwarz-Weiss-Reportage zeigt Aromen-Verkostung mit Duftstreifen, Probengläsern und strengem dokumentarischen Stil, Illustration mit AI erstellt.

Givaudan stock (ISIN CH0010645932) was at EUR 3,692.50 at Lang & Schwarz on October 12, 2026 at 10:51 a.m. CEST. Markets Insider reported on October 8, 2026 that Bernstein analyst Victoria Nice maintained a Sell rating with a CHF 2,886.00 price target. The contrast with recent bullish research gives the stock a clear valuation debate.

Three dated milestones

On July 23, 2026, Givaudan reported first-half sales of CHF 3.8 billion, up 3.6 percent on a like-for-like basis, according to Givaudan. On October 5, 2026, Barclays upgraded the stock to Overweight and lifted its target from CHF 3,450.00 to CHF 3,850.00, as Markets Insider reported. Bernstein then maintained its Sell view at CHF 2,886.00 on October 8, 2026.

What does the split view mean?

The two targets differ by CHF 964.00, while Givaudan's first-half sales grew 3.6 percent like-for-like. Barclays pointed to improving Taste and Wellbeing prospects, whereas Bernstein's lower target shows that expectations remain divided around growth and valuation.

Yahoo Finance reported on October 5, 2026 that Barclays expected third-quarter organic sales growth of 5.6 percent and fourth-quarter growth of 6.1 percent. The same report identified weaker Taste and Wellbeing demand and raw-material inflation as risks, while Givaudan's first-half Fragrance and Beauty growth reached 6.5 percent.

Results dates come into view

Givaudan is scheduled to report third-quarter results on October 13, 2026, according to Yahoo Finance. Fiscal-year 2026 results are listed for January 27, 2027 by Stock Analysis. These dates put the next operating update close to the current analyst disagreement.

Stock price and company profile

At Lang & Schwarz, Givaudan was at EUR 3,692.50 on October 12, 2026 at 10:51 a.m. CEST. The primary listing is on SIX under ticker GIVN, where the finance quote showed CHF 3,445.00 at 10:41 a.m. CEST on the same date. Market capitalization was CHF 31.8 billion, and the reported 52-week range was CHF 2,566.00 to CHF 3,592.00.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.